Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease
A comprehensive review of IGF2 as a neurotrophic therapeutic agent for Alzheimer's disease. This article examines IGF2's neuroprotective mechanisms, effects on cognition and neuroplasticity, therapeutic tolerability, and potential as both a preventive and treatment intervention for AD.